This is because BiTEs mediate target cell killing mainly via (non-tumor) antigen-experienced T cells that differentiate to effector memory T cells after activation and these cells can be reactivated without costimulatory signals such as CD28 and IL-2 [28]. Here, CD28 is linked to neoplasm.